NAVIPPRO Signal is a monthly e-newsletter focusing on the specific needs of pharmaceutical and public health professionals involved in the risk management of opioid analgesics and prescription stimulants. Committed to your interests and needs, NAVIPPRO Signal offers an exciting format with streamlined information, including industry news, interviews with leaders in the pain management field, and details about the NAVIPPRO™ system’s complete risk management solution. 

Sign up for the NAVIPPRO Signal newsletter by submitting your e-mail address and you will receive the latest issue of NAVIPPRO Signal each month, sent directly to your inbox.

Inflexxion will not sell or share your email address and you will only receive the newsletters that you select. You may unsubscribe to any newsletter, at anytime, by clicking on the unsubscribe link at the bottom of each newsletter.